IL‑33/ST2 pathway in a bleomycin‑induced pulmonary fibrosis model

Xu,Jiao; Zheng,Jinxu; Song,Ping; Zhou,Yanjuan; Guan,Shuhong

doi:10.3892/mmr.2016.5446

IL‑33/ST2 pathway in a bleomycin‑induced pulmonary fibrosis model

Authors:
- Jiao Xu
- Jinxu Zheng
- Ping Song
- Yanjuan Zhou
- Shuhong Guan
View Affiliations

Affiliations: Department of Respiratory Medicine, Changzhou Wujin People's Hospital, Changzhou, Jiangsu 213017, P.R. China, Department of Respiratory Medicine, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212000, P.R. China, Department of Respiratory Medicine, The Third Affiliated Hospital of Soochow University, The First People's Hospital of Changzhou, Changzhou, Hunan 213003, P.R. China
Published online on: June 27, 2016 https://doi.org/10.3892/mmr.2016.5446
Pages: 1704-1708

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the interleukin (IL)‑33/ST2 pathway in a model of acute pulmonary fibrosis, and to examine the pathogenesis of pulmonary fibrosis. The pulmonary fibrosis model was established by a single exposure to bleomycin (BLM group) endotracheally to represent idiopathic pulmonary fibrosis, and a control (Cont) group was treated with the same volume of saline. The degrees of acute injury, inflammation and fibrosis were detected using hematoxylin and eosin and Masson's staining. The IL‑33, ST2, myeloid differentiation primary response 88 (MyD88) and tumor necrosis factor receptor‑associated factor 6 (TRAF6) proteins were detected using Western blotting. The serum levels of IL‑4 and IL‑13 were detected using an enzyme‑linked immunosorbent assay. The results indicated that, compared with the Cont group, there were significant differences in the alveolitis scores in the BLM group on days 3, 7, 14 and 28 (P<0.01). The grades of fibrosis were also significantly different on days 7, 14 and 28 (P<0.01). On examining the dynamic protein expression levels of IL‑33, ST2, MyD88 and TRAF6, the expression of IL‑33 in the BLM group increased initially, and then decreased gradually following a peak on day 7. The significant differences between the BLM and Cont groups were observed on days 3 and 7 (P<0.05). Compared with the Cont group, the protein levels of ST2, MyD88 and TRAF6 in the BLM group exhibited an increasing trend from day 3, with significant differences, compared with the Cont group, on days 3, 7, 14 and 28 (P<0.05). On examination of the serum levels of IL‑4 and IL‑13 in each group, the levels of IL‑4 and IL‑13 in BLM group remained higher from day 7, with peaks on day 28, and were significantly different, compared with the Cont group, on days 7, 14 and 28 (P<0.05). In conclusion, the IL‑33/ST2 signaling pathway was found to be involved in the rodent model of pulmonary fibrosis induced by bleomycin.

View Figures

View References

1	Takenaka K, Gemma A, Yoshimura A, Hosoya Y, Nara M, Hosomi Y, Okano T, Kunugi S, Koizumi K, Fukuda Y, et al: Reduced transcription of the Smad 4 gene during pulmonary carcinogenesis in idiopathic pulmonary fibrosis. Mol Med Rep. 2:73–80. 2009.PubMed/NCBI
2	du Bois RM: Idiopathic pulmonary fibrosis: Present understanding and future options. Eur Respir Rev. 20:132–133. 2011. View Article : Google Scholar : PubMed/NCBI
3	Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG and Brown KK: Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med. 176:277–284. 2007. View Article : Google Scholar : PubMed/NCBI
4	Khalil N, O'Connor RN, Flanders KC and Unruh H: TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: An immunohistochemical study. Am J Respir Cell Mol Biol. 14:131–138. 1996. View Article : Google Scholar : PubMed/NCBI
5	Villar J, Cabrera N, Valladares F, Casula M, Flores C, Blanch L, Quilez M, Santana-Rodriguez N, Kacmarek R and Slutsky A: Activation of the Wnt/b-Catenin signaling pathway by mechanical ventilation is associated with ventilator-induced pulmonary fibrosis in healthy lungs. PLoS One. 6:e239142012. View Article : Google Scholar
6	Zhang Y, Li Y, Li Y, Li R, Ma Y, Wang H and Wang Y: Chloroquine inhibits MGC803 gastric cancer cell migration via the Toll-like receptor 9/nuclear factor kappa B signaling pathway. Mol Med Rep. 11:1366–1371. 2015.
7	Zhang Z, Chen N, Liu JB, Wu JB, Zhang J, Zhang Y and Jiang X: Protective effect of resveratrol against acute lung injury induced by lipopolysaccharide via inhibiting the myd88-dependent Toll-like receptor 4 signaling pathway. Mol Med Rep. 10:101–106. 2014.PubMed/NCBI
8	Kuroiwa K, Arai T, Okazaki H, Minota S and Tominaga S: Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem Biophys Res Commun. 284:1104–1108. 2001. View Article : Google Scholar : PubMed/NCBI
9	Lax A, Sanchez-Mas J, Asensio-Lopez MC, Fernandez-Del Palacio MJ, Caballero L, Garrido IP, Pastor-Perez FJ, Jauzzi JL and Pascual-Figal DA: Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction. JACC Heart Fail. 3:50–58. 2015. View Article : Google Scholar
10	Marvie P, Lisbonne M, L'Helgoualc'h A, Rauch M, Turlin B, Preisser L, Bourd-Boittin K, Théret N, Gascan H, Piquet-Pellorce C and Samson M: Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J Cell Mol Med. 14:1726–1739. 2010. View Article : Google Scholar
11	The Ministry of Science and Technology of the People's Republic of China: Guidance Suggestions for the Care and Use of Laboratory Animals. http://www.most.gov.cn/eng/pressroom/. Accessed September 30, 2006.
12	Tao Z and Li HP: Comparison of mouse pulmonary fibrosis models induced by bleomycin at different doses. Zhongguo zuzhi gongcheng yanjiu yu linchuang kangfu. 13:1214–1218. 2009.In Chinese.
13	Szapiel SV, Elson NA, Fulmer JD, Hunninghake GW and Crystal RG: Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis. 120:893–899. 1979.PubMed/NCBI
14	Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, et al: IL-33, an Interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 23:479–490. 2005. View Article : Google Scholar : PubMed/NCBI
15	Baekkevold ES, Roussigné M, Yamanaka T, Johansen FE, Jahnsen FL, Amalric F, Brandtzaeg P, Erard M, Haraldsen G and Girard JP: Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol. 163:69–79. 2003. View Article : Google Scholar : PubMed/NCBI
16	Borish L and Steinke JW: Interleukin-33 in Asthma: How big of a role does it play? Curr Allergy Asthma Rep. 11:7–11. 2011. View Article : Google Scholar :
17	Tominaga S: A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett. 258:301–304. 1989. View Article : Google Scholar : PubMed/NCBI
18	Yanagisawa K, Tsukamoto T, Takagi T and Tominaga S: Murine ST2 gene is a member of the primary response gene family induced by growth factors. FEBS Lett. 302:51–53. 1992. View Article : Google Scholar : PubMed/NCBI
19	Bergers G, Reikerstorfer A, Braselmann S, Graninger P and Busslinger M: Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 13:1176–1188. 1994.PubMed/NCBI
20	Xu D, Chan WL, Leung BP, Huang Fp, Wheeler R, Piedrafita D, Robinson JH and Liew FY: Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med. 187:787–794. 1998. View Article : Google Scholar : PubMed/NCBI
21	Löhning M, Stroehmann A, Coyle AJ, Grogan JL, Lin S, Gutierrez-Ramos JC, Levinson D, Radbruch A and Kamradt T: T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA. 95:6930–6935. 1998. View Article : Google Scholar : PubMed/NCBI
22	Sandler NG, Mentink-Kane MM, Cheever AW and Wynn TA: Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J Immunol. 171:3655–3667. 2003. View Article : Google Scholar : PubMed/NCBI
23	Rubartelli A and Lotze MT: Inside, outside, upside down: Damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 28:429–436. 2007. View Article : Google Scholar : PubMed/NCBI
24	Tajima S, Oshikawa K, Tominaga S and Sugiyama Y: The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest. 124:1206–1214. 2003. View Article : Google Scholar : PubMed/NCBI
25	du Bois RM: Strategies for treating idiopathic pulmonary fibrosis. Nat Rev Drug Discov. 9:129–140. 2010. View Article : Google Scholar : PubMed/NCBI
26	Meltzer EB and Noble PW: Idiopathic pulmonary fibrosis. Orphanet J Rare Dis. 3:82008. View Article : Google Scholar : PubMed/NCBI
27	Selman M, King TE and Pardo A; American Thoracic Society; European Respiratory Society; American College of Chest Physicians: Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 134:136–151. 2001. View Article : Google Scholar : PubMed/NCBI
28	Hayakawa H, Hayakawa M, Kume A and Tominaga S: Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem. 282:26369–26380. 2010. View Article : Google Scholar